Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
BURLINGAME, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Ablexis, LLC, a biopharmaceutical company focused on licensing its AlivaMab Mouse technology for antibody drug discovery, today announced a...
-
BURLINGAME, Calif., Sept. 14, 2017 (GLOBE NEWSWIRE) -- Ablexis, LLC, a biopharmaceutical company focused on licensing its AlivaMab Mouse technology for antibody drug discovery, today announced a...
-
-- Ablexis Looks Forward to Establishing Additional Non-Exclusive Partnerships in 2017 -- BURLINGAME, Calif., Feb. 14, 2017 (GLOBE NEWSWIRE) -- Ablexis, LLC today announced a licensing agreement...
-
BURLINGAME, Calif., Jan. 12, 2017 (GLOBE NEWSWIRE) -- Ablexis, LLC announced today that it has entered into a non-exclusive, perpetual license agreement with the Tri-Institutional Therapeutics...